InvestorsHub Logo
Followers 35
Posts 4279
Boards Moderated 0
Alias Born 12/12/2007

Re: None

Sunday, 08/09/2020 12:32:52 PM

Sunday, August 09, 2020 12:32:52 PM

Post# of 401439
NORTHVALE, NJ / ACCESSWIRE / September 12, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, today announced that it received approval from the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application (ANDA) for a generic version of Tylenol® with Codeine (acetaminophen and codeine phosphate) 300mg/15mg, 300mg/30mg, and 300mg/60mg tablets.

Sales brand and Generics $45 Million

Number of Competitor Including brand per FDA Site or CC - 7

Will be launched 2020 calendar


ELTP$$$$


https://finance.yahoo.com/news/elite-pharmaceuticals-receives-fda-approval-110000701.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News